{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T11:50:40Z","timestamp":1759665040536},"reference-count":43,"publisher":"Pharmaceutical Society of Japan","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological &amp; Pharmaceutical Bulletin","Biol. Pharm. Bull."],"published-print":{"date-parts":[[2016]]},"DOI":"10.1248\/bpb.b16-00080","type":"journal-article","created":{"date-parts":[[2016,5,2]],"date-time":"2016-05-02T18:04:12Z","timestamp":1462212252000},"page":"1224-1230","source":"Crossref","is-referenced-by-count":14,"title":["Radiosensitizing Effect of TRPV1 Channel Inhibitors in Cancer Cells"],"prefix":"10.1248","volume":"39","author":[{"given":"Keisuke","family":"Nishino","sequence":"first","affiliation":[{"name":"Department of Radiation Biosciences, Faculty of Pharmaceutical Sciences, Tokyo University of Science"},{"name":"Department of Biochemistry, Faculty of Pharmaceutical Sciences, Tokyo University of Science"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keisuke","family":"Tanamachi","sequence":"additional","affiliation":[{"name":"Department of Radiation Biosciences, Faculty of Pharmaceutical Sciences, Tokyo University of Science"},{"name":"Department of Biochemistry, Faculty of Pharmaceutical Sciences, Tokyo University of Science"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuto","family":"Nakanishi","sequence":"additional","affiliation":[{"name":"Department of Radiation Biosciences, Faculty of Pharmaceutical Sciences, Tokyo University of Science"},{"name":"Department of Biochemistry, Faculty of Pharmaceutical Sciences, Tokyo University of Science"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunta","family":"Ide","sequence":"additional","affiliation":[{"name":"Department of Radiation Biosciences, Faculty of Pharmaceutical Sciences, Tokyo University of Science"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuji","family":"Kojima","sequence":"additional","affiliation":[{"name":"Department of Radiation Biosciences, Faculty of Pharmaceutical Sciences, Tokyo University of Science"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sei-ichi","family":"Tanuma","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Faculty of Pharmaceutical Sciences, Tokyo University of Science"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsutoshi","family":"Tsukimoto","sequence":"additional","affiliation":[{"name":"Department of Radiation Biosciences, Faculty of Pharmaceutical Sciences, Tokyo University of Science"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"163","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Nosaki K, Seto T. The role of radiotherapy in the treatment of small-cell lung cancer. <i>Curr. Treat. Options Oncol.<\/i>, <b>16<\/b>, 56 (2015).","DOI":"10.1007\/s11864-015-0372-2"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Ohnishi T, Mori E, Takahashi A. DNA double-strand breaks: their production, recognition, and repair in eukaryotes. <i>Mutat. Res.<\/i>, <b>669<\/b>, 8\u201312 (2009).","DOI":"10.1016\/j.mrfmmm.2009.06.010"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Vilenchik MM, Knudson AG. Endogenous DNA double-strand breaks: production, fidelity of repair, and induction of cancer. <i>Proc. Natl. Acad. Sci. U.S.A.<\/i>, <b>100<\/b>, 12871\u201312876 (2003).","DOI":"10.1073\/pnas.2135498100"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Chiruvella KK, Liang Z, Wilson TE. Repair of double-strand breaks by end joining. <i>Cold Spring Harb. Perspect. Biol.<\/i>, <b>5<\/b>, a012757 (2013).","DOI":"10.1101\/cshperspect.a012757"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Shrivastav M, De Haro LP, Nickoloff JA. Regulation of DNA double-strand break repair pathway choice. <i>Cell Res.<\/i>, <b>18<\/b>, 134\u2013147 (2008).","DOI":"10.1038\/cr.2007.111"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Lisby M, Rothstein R. Choreography of recombination proteins during the DNA damage response. <i>DNA Repair<\/i> (Amst.), <b>8<\/b>, 1068\u20131076 (2009).","DOI":"10.1016\/j.dnarep.2009.04.007"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Fillingham J, Keogh M-C, Krogan NJ. GammaH2AX and its role in DNA double-strand break repair. <i>Biochem. Cell Biol.<\/i>, <b>84<\/b>, 568\u2013577 (2006).","DOI":"10.1139\/o06-072"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Klein HL. The consequences of Rad51 overexpression for normal and tumor cells. <i>DNA Repair<\/i> (Amst.), <b>7<\/b>, 686\u2013693 (2008).","DOI":"10.1016\/j.dnarep.2007.12.008"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Koukourakis MI, Giatromanolaki A, Kakolyris S, Sivridis E, Georgoulias V, Funtzilas G, Hickson ID, Gatter KC, Harris AL. Nuclear expression of human apurinic\/apyrimidinic endonuclease (HAP1\/Ref-1) in head-and-neck cancer is associated with resistance to chemoradiotherapy and poor outcome. <i>Int. J. Radiat. Oncol. Biol. Phys.<\/i>, <b>50<\/b>, 27\u201336 (2001).","DOI":"10.1016\/S0360-3016(00)01561-3"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Igney FH, Krammer PH. Death and anti-death: tumour resistance to apoptosis. <i>Nat. Rev. Cancer<\/i>, <b>2<\/b>, 277\u2013288 (2002).","DOI":"10.1038\/nrc776"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Brown JM, Wilson WR. Exploiting tumor hypoxia in cancer treatment. <i>Nat. Rev. Cancer<\/i>, <b>4<\/b>, 437\u2013447 (2004).","DOI":"10.1038\/nrc1367"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Pouyss\u00e9gur J, Dayan F, Mazure NM. Hypoxia signaling in cancer and approaches to enforce tumour regression. <i>Nature<\/i>, <b>441<\/b>, 437\u2013443 (2006).","DOI":"10.1038\/nature04871"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Wilson WR, Hay MP. Targeting hypoxia in cancer therapy. <i>Nat. Rev. Cancer<\/i>, <b>11<\/b>, 393\u2013410 (2011).","DOI":"10.1038\/nrc3064"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Elkind MM, Sutton-Gilbert H, Moses WB, Kamper C. Sub-lethal and lethal radiation damage. <i>Nature<\/i>, <b>214<\/b>, 1088\u20131092 (1967).","DOI":"10.1038\/2141088a0"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Wada M, Suzuki M, Liu C, Kaneko Y, Fukuda S, Ando K, Matsufuji N. Modeling the biological response of normal human cells, including repair processes, to fractionated carbon beam irradiation. <i>J. Radiat. Res.<\/i>, <b>54<\/b>, 798\u2013807 (2013).","DOI":"10.1093\/jrr\/rrt012"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Mesbahi A. A review on gold nanoparticles radiosensitization effect in radiation therapy of cancer. <i>Rep. Pract. Oncol. Radiother<\/i>, <b>15<\/b>, 176\u2013180 (2010).","DOI":"10.1016\/j.rpor.2010.09.001"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Schilling D, K\u00fchnel A, Konrad S, Tetzlaff F, Bayer C, Yaglom J, Multhoff G. Sensitizing tumor cells to radiation by targeting the heat shock response. <i>Cancer Lett.<\/i>, <b>360<\/b>, 294\u2013301 (2015).","DOI":"10.1016\/j.canlet.2015.02.033"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Bekker-Jensen S, Mailand N. Assembly and function of DNA double-strand break repair foci in mammalian cells. <i>DNA Repair<\/i> (Amst.), <b>9<\/b>, 1219\u20131228 (2010).","DOI":"10.1016\/j.dnarep.2010.09.010"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Ayrapetov MK, Gursoy-Yuzugullu O, Xu C, Xu Y, Price BD. DNA double-strand breaks promote methylation of histone H3 on lysine 9 and transient formation of repressive chromatin. <i>Proc. Natl. Acad. Sci. U.S.A.<\/i>, <b>111<\/b>, 9169\u20139174 (2014).","DOI":"10.1073\/pnas.1403565111"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Masumoto K, Tsukimoto M, Kojima S. Role of TRPM2 and TRPV1 cation channels in cellular responses to radiation-induced DNA damage. <i>Biochim. Biophys. Acta<\/i>, <b>1830<\/b>, 3382\u20133390 (2013).","DOI":"10.1016\/j.bbagen.2013.02.020"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Ferrer-Montiel A, Fern\u00e1ndez-Carvajal A, Planells-Cases R, Fern\u00e1ndez-Ballester G, Gonz\u00e1lez-Ros JM, Messeguer A, Gonz\u00e1lez-Mu\u00f1iz R. Advances in modulating thermosensory TRP channels. <i>Expert. Opin. Ther. Pat<\/i>, <b>22<\/b>, 999\u20131017 (2012).","DOI":"10.1517\/13543776.2012.711320"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Naz\u0131ro\u011flu M. Molecular role of catalase on oxidative stress-induced Ca<sup>2+<\/sup> signaling and TRP cation channel activation in nervous system. <i>J. Recept. Signal Transduct. Res.<\/i>, <b>32<\/b>, 134\u2013141 (2012).","DOI":"10.3109\/10799893.2012.672994"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Fragkos M, Beard P. Mitotic catastrophe occurs in the absence of apoptosis in p53-null cells with a defective G1 checkpoint. <i>PLoS ONE<\/i>, <b>6<\/b>, e22946 (2011).","DOI":"10.1371\/journal.pone.0022946"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Cornago M, Garcia-Alberich C, Blasco-Angulo N, Vall-Llaura N, Nager M, Herreros J, Comella JX, Sanchis D, Llovera M. Histone deacetylase inhibitors promote glioma cell death by G2 checkpoint abrogation leading to mitotic catastrophe. <i>Cell Death Dis.<\/i>, <b>5<\/b>, e1435 (2014).","DOI":"10.1038\/cddis.2014.412"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Sabin RJ, Anderson RM. Cellular senescence\u2014its role in cancer and the response to ionizing radiation. <i>Genome Integr.<\/i>, <b>2<\/b>, 7 (2011).","DOI":"10.1186\/2041-9414-2-7"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Vitale I, Galluzzi L, Castedo M, Kroemer G. Mitotic catastrophe: a mechanism for avoiding genomic instability. <i>Nat. Rev. Mol. Cell Biol.<\/i>, <b>12<\/b>, 385\u2013392 (2011).","DOI":"10.1038\/nrm3115"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Jain S, Hirst DG, O\u2019Sullivan JM. Gold nanoparticles as novel agents for cancer therapy. <i>Br. J. Radiol.<\/i>, <b>85<\/b>, 101\u2013113 (2012).","DOI":"10.1259\/bjr\/59448833"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Cooper DR, Bekah D, Nadeau JL. Gold nanoparticles and their alternatives for radiation therapy enhancement. <i>Front. Chem.<\/i>, <b>2<\/b>, 86 (2014).","DOI":"10.3389\/fchem.2014.00086"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Lu X, Xiao L, Wang L, Ruden DM. Hsp90 inhibitors and drug resistance in cancer: the potential benefits of combination therapies of Hsp90 inhibitors and other anti-cancer drugs. <i>Biochem. Pharmacol.<\/i>, <b>83<\/b>, 995\u20131004 (2012).","DOI":"10.1016\/j.bcp.2011.11.011"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Sancey L, Lux F, Kotb S, Roux S, Dufort S, Bianchi A, Cr\u00e9millieux Y, Fries P, Coll J-L, Rodriguez-Lafrasse C, Janier M, Dutreix M, Barberi-Heyob M, Boschetti F, Denat F, Louis C, Porcel E, Lacombe S, Le Duc G, Deutsch E, Perfettini J-L, Detappe A, Verry C, Berbeco R, Butterworth KT, McMahon SJ, Prise KM, Perriat P, Tillement O. The use of theranostic gadolinium-based nanoprobes to improve radiotherapy efficacy. <i>Br. J. Radiol.<\/i>, <b>87<\/b>, 20140134 (2014).","DOI":"10.1259\/bjr.20140134"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Jan\u010dula D, Mar\u0161\u00e1lek B. Critical review of actually available chemical compounds for prevention and management of cyanobacterial blooms. <i>Chemosphere<\/i>, <b>85<\/b>, 1415\u20131422 (2011).","DOI":"10.1016\/j.chemosphere.2011.08.036"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32) Masunaga S, Ono K, Hori H, Suzuki M, Kinashi Y, Takagaki M, Kasai S, Nagasawa H, Uto Y. Change in oxygenation status in intratumour total and quiescent cells following gamma-ray irradiation, tirapazamine administration, cisplatin injection and bleomycin treatment. <i>Br. J. Radiol.<\/i>, <b>73<\/b>, 978\u2013986 (2000).","DOI":"10.1259\/bjr.73.873.11064652"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33) Matsumoto H, Hamada N, Takahashi A, Kobayashi Y, Ohnishi T. Vanguards of paradigm shift in radiation biology: radiation-induced adaptive and bystander responses. <i>J. Radiat. Res.<\/i>, <b>48<\/b>, 97\u2013106 (2007).","DOI":"10.1269\/jrr.06090"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34) Ohshima Y, Tsukimoto M, Takenouchi T, Harada H, Suzuki A, Sato M, Kitani H, Kojima S. \u03b3-Irradiation induces P2X(7) receptor-dependent ATP release from B16 melanoma cells. <i>Biochim. Biophys. Acta<\/i>, <b>1800<\/b>, 40\u201346 (2010).","DOI":"10.1016\/j.bbagen.2009.10.008"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35) Tsukimoto M, Homma T, Ohshima Y, Kojima S. Involvement of purinergic signaling in cellular response to gamma radiation. <i>Radiat. Res.<\/i>, <b>173<\/b>, 298\u2013309 (2010).","DOI":"10.1667\/RR1732.1"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36) Nishimaki N, Tsukimoto M, Kitami A, Kojima S. Autocrine regulation of \u03b3-irradiation-induced DNA damage response <i>via<\/i> extracellular nucleotides-mediated activation of P2Y6 and P2Y12 receptors. <i>DNA Repair<\/i> (Amst.), <b>11<\/b>, 657\u2013665 (2012).","DOI":"10.1016\/j.dnarep.2012.05.005"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37) Ohshima Y, Tsukimoto M, Harada H, Kojima S. Involvement of connexin43 hemichannel ATP release after \u03b3-irradiation. <i>J. Radiat. Res.<\/i>, <b>53<\/b>, 551\u2013557 (2012).","DOI":"10.1093\/jrr\/rrs014"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38) Alawi K, Keeble J. The paradoxical role of the transient receptor potential vanilloid 1 receptor in inflammation. <i>Pharmacol. Ther.<\/i>, <b>125<\/b>, 181\u2013195 (2010).","DOI":"10.1016\/j.pharmthera.2009.10.005"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39) Fernandes ES, Liang L, Smillie SJ, Kaiser F, Purcell R, Rivett DW, Alam S, Howat S, Collins H, Thompson SJ, Keeble JE, Riffo-Vasquez Y, Bruce KD, Brain SD. TRPV1 deletion enhances local inflammation and accelerates the onset of systemic inflammatory response syndrome. <i>J. Immunol.<\/i>, <b>188<\/b>, 5741\u20135751 (2012).","DOI":"10.4049\/jimmunol.1102147"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40) Chen CW, Lee ST, Wu WT, Fu WM, Ho FM, Lin WW. Signal transduction for inhibition of inducible nitric oxide synthase and cyclooxygenase-2 induction by capsaicin and related analogs in macrophages. <i>Br. J. Pharmacol.<\/i>, <b>140<\/b>, 1077\u20131087 (2003).","DOI":"10.1038\/sj.bjp.0705533"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41) White JP, Urban L, Nagy I. TRPV1 function in health and disease. <i>Curr. Pharm. Biotechnol.<\/i>, <b>12<\/b>, 130\u2013144 (2011).","DOI":"10.2174\/138920111793937844"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42) Sousa-Valente J, Andreou AP, Urban L, Nagy I. Transient receptor potential ion channels in primary sensory neurons as targets for novel analgesics. <i>Br. J. Pharmacol.<\/i>, <b>171<\/b>, 2508\u20132527 (2014).","DOI":"10.1111\/bph.12532"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43) Wong GY, Gavva NR. Therapeutic potential of vanilloid receptor TRPV1 agonists and antagonists as analgesics: Recent advances and setbacks. <i>Brain Res. Rev.<\/i>, <b>60<\/b>, 267\u2013277 (2009).","DOI":"10.1016\/j.brainresrev.2008.12.006"}],"container-title":["Biological &amp; Pharmaceutical Bulletin","Biological and Pharmaceutical Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/39\/7\/39_b16-00080\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T08:33:07Z","timestamp":1498293187000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/39\/7\/39_b16-00080\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":43,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1248\/bpb.b16-00080","relation":{},"ISSN":["0918-6158","1347-5215"],"issn-type":[{"value":"0918-6158","type":"print"},{"value":"1347-5215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016]]}}}